• Regeneron Pharmaceuticals average return on assets for 2024 was 12.48, a 9.1% decline from 2023.
• Regeneron Pharmaceuticals average return on assets for 2023 was 13.73, a 39.49% decline from 2022.
• Regeneron Pharmaceuticals average return on assets for 2022 was 22.69, a 30.29% decline from 2021.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.